Filing Details
- Accession Number:
- 0001628908-23-000047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-07 18:06:34
- Reporting Period:
- 2023-03-03
- Accepted Time:
- 2023-03-07 18:06:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1628908 | Evolent Health Inc. | EVH | Services-Management Services (8741) | 320454912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643346 | Seth Blackley | C/O Evolent Health, Inc. 800 N. Glebe Road, Suite 500 Arlington VA 22203 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-03-03 | 360,000 | $0.00 | 951,994 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-03-06 | 71,916 | $34.40 | 880,078 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-03-06 | 2,012 | $35.01 | 878,066 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-03-07 | 95,055 | $34.62 | 783,011 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Leveraged Restricted Stock Unit | Disposition | 2023-03-03 | 360,000 | $0.00 | 360,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Footnotes
- Represents the vesting of the leveraged stock units ("LSUs") granted to Mr. Blackley on March 2, 2020, based on the cumulative performance of the Issuer's Class A Common Stock.
- Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- This number represents shares of Class A Common Stock sold to satisfy the tax withholding obligation due upon vesting of LSUs.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.95 to $34.93, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.975 to $35.060, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.35 to $34.92, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- LSUs vested on March 3, 2023.
- These LSUs do not expire.
Billionaire Hedge Funds
